Investigators at the University of Pittsburgh have developed a system capable of sustainably releasing the appropriate chemokines in a manner that mimics the body’s processes.

About

Technology:

Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells) and chondrocytes (cartilage cells), and possess both a regenerative and regulatory potential. These cells may be used as immunosuppressive and anti-inflammatory agents. During injury or inflammation, the body will migrate these cells to the site of damage. Investigators at the University of Pittsburgh have developed a system capable of sustainably releasing the appropriate chemokines in a manner that mimics the body’s natural process to attract MSC cells to a desired site. 

Applications:

* Potential treatment for diseases of inflammation including rheumatoid arthritis or psoriasis, or by inflammatory conditions such as inflammatory bowel disease or atherosclerosis.
* May be useful in wound healing application
 

Purchase a license for full unlimited access to all innovation profiles on LEO

  • Direct connection to thousands of more innovations
  • Access to market Experts and Universities
  • Filter relevant solutions into your own dedicated Network